+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Intellipharmaceutics International Inc (I) - Financial and Strategic SWOT Analysis Review

  • ID: 4281439
  • SWOT Analysis
  • March 2018
  • Region: Global
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4


  • Aptose Biosciences Inc
  • Health Systems Group
  • Migenix Inc
  • Sernova Corp
  • MORE

Intellipharmaceutics International Inc (Intellipharmaceutics) is a research based pharmaceutical company that develops, manufactures, and commercializes novel and generic targeted oral solid dosage pharmaceuticals. The company’s portfolio encompasses controlled-release candidates for management of neuropathic pain, attention deficit hyperactivity disorder (ADHD), schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder and panic disorder; type 2 diabetes; and stomach ulcers. It offers a comprehensive range of pre-formulation studies, design, and development through to regulatory approval. The company’s drug delivery systems and pipeline candidates are based on its Hypermatrix, a proprietary multidimensional controlled-release drug delivery technology. Intellipharmaceutics’ is headquartered in Toronto, Ontario, Canada.

Intellipharmaceutics International Inc Key Recent Developments

Jan 24, 2018: Intellipharmaceutics Provides Operational Update
Oct 10, 2017: Intellipharmaceutics Announces Third Quarter 2017 Results
Sep 01, 2017: Intellipharmaceutics appoints new Chief Financial Officer
Sep 01, 2017: Intellipharmaceutics Appoints New Chief Financial Officer
Aug 08, 2017: Intellipharmaceutics Announces Resignation of CFO

This comprehensive SWOT profile of Intellipharmaceutics International Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Intellipharmaceutics International Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 4


  • Aptose Biosciences Inc
  • Health Systems Group
  • Migenix Inc
  • Sernova Corp
  • MORE
Section 1 - About the Company
  • Intellipharmaceutics International Inc - Key Information
  • Intellipharmaceutics International Inc - Overview
  • Intellipharmaceutics International Inc - Key Employees
  • Intellipharmaceutics International Inc - Key Employee Biographies
  • Intellipharmaceutics International Inc - Key Operational Heads
  • Intellipharmaceutics International Inc - Major Products and Services
  • Intellipharmaceutics International Inc - History
  • Intellipharmaceutics International Inc - Company Statement
  • Intellipharmaceutics International Inc - Locations And Subsidiaries
  • Intellipharmaceutics International Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Intellipharmaceutics International Inc - Business Description
  • Intellipharmaceutics International Inc - Corporate Strategy
  • Intellipharmaceutics International Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Intellipharmaceutics International Inc - Strengths
  • Intellipharmaceutics International Inc - Weaknesses
  • Intellipharmaceutics International Inc - Opportunities
  • Intellipharmaceutics International Inc - Threats
  • Intellipharmaceutics International Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Intellipharmaceutics International Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Intellipharmaceutics International Inc, Key Information
  • Intellipharmaceutics International Inc, Key Ratios
  • Intellipharmaceutics International Inc, Share Data
  • Intellipharmaceutics International Inc, Major Products and Services
  • Intellipharmaceutics International Inc, History
  • Intellipharmaceutics International Inc, Key Employees
  • Intellipharmaceutics International Inc, Key Employee Biographies
  • Intellipharmaceutics International Inc, Key Operational Heads
  • Intellipharmaceutics International Inc, Other Locations
  • Intellipharmaceutics International Inc, Subsidiaries
  • Intellipharmaceutics International Inc, Key Manufacturing facilities
  • Intellipharmaceutics International Inc, Key Competitors
  • Intellipharmaceutics International Inc, SWOT Analysis
  • Intellipharmaceutics International Inc, Ratios based on current share price
  • Intellipharmaceutics International Inc, Annual Ratios
  • Intellipharmaceutics International Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Intellipharmaceutics International Inc, Performance Chart
  • Intellipharmaceutics International Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4


4 of 4
  • Sernova Corp
  • Migenix Inc
  • Health Systems Group
  • Generex Biotechnology Corp
  • Aptose Biosciences Inc
Note: Product cover images may vary from those shown